Low-dose combinations versus monotherapies in the treatment of hypertension.

Détails

ID Serval
serval:BIB_2311
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Low-dose combinations versus monotherapies in the treatment of hypertension.
Périodique
Journal of Hypertension
Auteur⸱e⸱s
Waeber B., Brunner H.R.
ISSN
0952-1178
Statut éditorial
Publié
Date de publication
1997
Volume
15
Numéro
2
Pages
S17-S20
Langue
anglais
Notes
Publication types: Journal Article ; Review
Résumé
RATIONALE FOR DRUG COMBINATIONS: Essential hypertension is a heterogeneous disease. Different factors might interact, in an individual patient, to increase blood pressure. This explains why a drug that lowers blood pressure by a given mechanism may normalize blood pressure in some patients but not in others. combining two drugs with complementary mechanisms of action can increase the antihypertensive efficacy. DOSAGES USED IN DRUG COMBINATIONS: When administered in combination, lower doses of the separate components are generally necessary than when the drugs are prescribed as monotherapies, which may improve tolerability. Fixed-dose combination therapy is therefore an attractive approach to the treatment of hypertensive patients. It may be an appropriate choice, not only for second-line, but also for first-line therapy.
Mots-clé
Antihypertensive Agents, Clinical Trials as Topic, Drug Therapy, Combination, Humans, Hypertension
Pubmed
Web of science
Création de la notice
19/11/2007 13:18
Dernière modification de la notice
20/08/2019 14:00
Données d'usage